Translation and Validation of the MQOL Self-questionnaire Into French for Assessing Quality of Life in Patients With Meningiomas

Launched by CENTRE HOSPITALIER ST ANNE · Jun 23, 2025

Keywords

ClinConnect Summary

This clinical trial is focused on creating and testing a French version of a questionnaire called the MQOL, which helps measure the quality of life in people with meningiomas. Meningiomas are a type of brain tumor that can affect not just physical health but also emotional and social well-being. While there is already a questionnaire in English to understand how these tumors impact patients’ lives, it hasn’t been translated into French yet. This study will first translate and make sure the French version reads well, then test it with 50 patients who have meningiomas to confirm it works well and gives reliable results.

If you are 18 years or older and have a confirmed diagnosis of a meningioma (a brain tumor), you could be eligible to take part in this study. Participants will be asked to complete the translated questionnaire along with other well-known health surveys to help researchers see if the new French version accurately reflects patients’ experiences. It’s important to note that pregnant or breastfeeding women, people who don’t understand French well, or those under certain legal or psychiatric restrictions cannot join. This trial aims to give French-speaking patients and doctors a useful tool to better understand and improve quality of life for people living with meningiomas.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patient aged 18 years or older
• • Diagnosis of intracranial meningioma confirmed by imaging or surgery
• Exclusion Criteria:
• • Pregnant or breastfeeding women (Article L1121-5)
• • Patients deprived of liberty by judicial or administrative decision, as well as individuals undergoing psychiatric care (Article L1121-6)
• • Patients not fluent in French or with poor understanding of the language
• • Inability to refuse participation in the study